Alopecia

  1. Gil-Redondo, R.
  2. Moreno-Arrones, O.M.
  3. Vañó-Galván, S.
  4. Jaén-Olasolo, P.
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2019

Issue Title: Actualidad clínico-terapéutica (IV)

Series: 12

Issue: 92

Pages: 5394-5404

Type: Article

DOI: 10.1016/J.MED.2019.12.002 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Alopecia is defined as the reversible or irreversible loss of hair follicles causing a diffuse loss of localized or hair density. They are classified as primary or secondary alopecia (caused by external agents). Primary alopecias are clasiffied into non-scarring alopecia (follicle is conserved) and scarring alopecia (hair follicle is destroyed being replaced with scar tissue). Effluviur, another hair disorder, are defined by a hair shedding, greater than physiological, causing or not a reduction in hair density. In this paper, we do a general approach to the patient consulting for hair loss, as well as specific treatment of the most common alopecia in our environment.

Bibliographic References

  • Camacho FM, Tosti A, Randall VA, Price VH. Montagna tricología. 3rd ed. Madrid: Grupo Aula Médica; 2013.
  • Tosti A. Dermoscopy of hair and nail disorders. 2nd ed. Boca Raton, FL: CRC Press; 2015.
  • Headington JT, Telogen effluvium. New concepts and review. Arch Der-matol. 1993;129(3):356-63.
  • Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient: part I. History and clinical exami-nation. J Am Acad Dermatol. 2014;71(3):415.e1-415.e15.
  • Kanwar A, Narang T. Anagen effluvium. Indian J Dermatol Venereol Le-prol. 2013;79(5):604.
  • Freites-Martínez A, Shapiro J, van den Hurk C, Goldfarb S, Jiménez JJ, Rossi AM, et al. Hair disorders in cancer survivors. J Am Acad Dermatol. 2019;80(5):1199-213.
  • Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9): WE01-03.
  • Gupta M, Mysore V. Classifications of patterned hair loss: a review. J Cutan Aesthet Surg. 2019;9(1):3-12.
  • Gopinath H, Upadya GM. Metabolic syndrome in androgenic alopecia. Indian J Dermatol Venereol Leprol. 2016;82(4):404-8.
  • Rudnicka L, Olszewska M, Rakowska A, Slowinska M. Trichosco-py update 2011. J Dermatol Case Rep. 2011;5(4):82-8.11.
  • Mardones F, Hott K, Martinez MC. Clinical study of fibrosing alopecia in a pattern distribution in a Latin American population. Int J Dermatol. 2018;57(2):e12-e14.
  • Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of du-tasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014; 70(3):489-498.e3.13.
  • Jiménez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, Her-mosa-Gelbard A, Moreno-Arrones OM, Fernández-Nieto D, et al. Effectiveness and safety of low-dose oral minoxidil in male androge-netic alopecia. J Am Acad Dermatol. 2019;81(2):648-9.
  • Vañó-Galván S, Camacho F. New treatments for hair loss. Actas Dermosifiliogr. 2017;108(3):221-8.
  • Kite A, Lucas VS. Hair transplant: a basic review. Plast Surg Nurs. 2015;35(2):66-8.
  • Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Na-gler AR. Androgens in women: Androgen-mediated skin disease and patient evaluation. J. Am Acad Dermatol. 2019;80:1497-506.17.
  • Sinclair RD. Female pattern hair loss: a pilot study investigating combi-nation therapy with lowdose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104-9
  • Azarchi S, Bienenfeld A, Lo Sicco K, Marchbein S, Shapiro J, Na-gler AR. Androgens in women: Hormone-modulating therapies for skin disease. J Am Acad Dermatol. 2019;80:1509-21.
  • Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, et al. Alopecia areata: Disease characteristics, clini-cal evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78(1):1-12.20.
  • Vañó-Galván S, Fernández-Crehuet P, Grimalt R, García-Hernández MJ, Rodrigues-Barata R, Arias-Santiago S, et al. Alopecia areata totalis and universalis: a multicenter review of 132 patients in Spain. J Eur Acad Dermatol Venereol. 2017;31(3):550-6.21.
  • Lee S, Lee Y Bin, Kim BJ, Lee W-S. Screening of thyroid function and autoantibodies in patients with alopecia areata: A systematic review and meta-analysis. J Am Acad Dermatol. 2019;80:1410-1413.e4.
  • Patel D, Li P, Bauer AJ, Castelo-Soccio L. Screening guidelines for thyroid function in children with alopecia areata. JAMA Dermatology. 2017;153:1307-10.23. Wang EHC, Sallee BN, Tejeda CI, Christiano AM. JAK Inhibitors for Treatment of Alopecia Areata. J Invest Dermatol. 2018;138(9):1911-6.24.
  • Vañó-Galván S, Molina-Ruiz AM, Serrano-Falcón C, Arias-Santiago S, Rodrigues-Barata AR, Garnacho-Saucedo G, et al. Fron-tal fibrosing alopecia: A multicenter review of 355 patients. J Am Acad Dermatol. 2014;70(4):670-8.25.
  • Moreno-Arrones OM, Saceda-Corralo D, Fonda-Pascual P, Ro-drigues-Barata AR, Buendía-Castaño D, Alegre-Sánchez A, et al. Frontal fibrosing alopecia: clinical and prognostic classification. J Eur Acad Dermatology Venereol. 2017;31(10):1739-45.26.
  • Vañó-Galván S, Saceda-Corralo D, Moreno-Arrones ÓM, Camacho-Martínez FM. Updated diagnostic criteria for frontal fibrosing alopecia. J Am Acad Dermatol. 2018;78:e21-e22.
  • Baibergenova A, Donovan J. Lichen planopilaris: update on pathogenesis and treatment. Skinmed. 2013;11(3):161-5.
  • Kuhn A, Aberer E, Bata-CsörgŃ Z, Caproni M, Dreher A, Frances C, et al. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2017;31:389-404.29.
  • Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, Rodrigues-Ba-rata AR, Arias-Santiago S, Serrano-Falcón C, et al. Folliculitis decalvans: a multicentre review of 82 patients. J Eur Acad Dermatol Venereol. 2015;29:1750-7.
Data source: Dialnet